Jacobi Medical Center Bronx

Site Details

LOCATION

Jacobi Medical Cernter, Bldg 1 Rm 1W5-14

1400 Pelham Parkway South

Bronx, NY . 10461

Get Directions

Site Type

CRS

CRS Coordinator

Marlene Burey

marlene.burey@nbhn.net

718-918-4783

CRS Leader

Andrew Wiznia

andrew.wiznia@einstein.yu.edu

718-918-4664

Site Trials

HIV (and comorbidities)

Open and enrolling

A5359: Long-Acting Antiretroviral Therapy in Non-adherent Persons Living with HIV (PLWH)

This four-step study compares Long-Acting (LA) Injectable Antiretroviral Therapy (ART) to standard of care (SOC) oral ART in previously non-adherent individuals.

· Step 1 is the induction phase and all participants receive SOC oral ART. Participants receive financial incentives for meeting study-specified goals.

· Step 2 is the randomization phase and participants are randomized 1:1 to receive LA injectable ART (cabotegravir and rilpivirine injections) or continue on SOC for 52 weeks.

· Step 3 is the crossover/continuation phase. Participants randomized to LA ART will continue that therapy, and eligible SOC participants will cross-over to receive LA ART for 52 weeks.

· Step 4 is the observational phase that switches participants who received at least one LA ART injection and are no longer eligible for injections back to locally sourced SOC oral ART for 52 weeks.

Mpox

Open and enrolling

A5418:Study of Tecovirimat for Human Monkeypox Virus (STOMP)

A5418 (STOMP) is a study of tecovirimat (also known as TPOXX) for the treatment of human monkeypox virus (HMPXV) disease.